Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMC 2111046)

Published in Am J Respir Crit Care Med on September 28, 2006

Authors

Satyan Lakshminrusimha1, James A Russell, Stephen Wedgwood, Sylvia F Gugino, Jeffrey A Kazzaz, Jonathan M Davis, Robin H Steinhorn

Author Affiliations

1: Department of Pediatrics, State University of New York at Buffalo, NY, USA. slakshmi@buffalo.edu

Articles citing this

Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal (2011) 2.66

Neonatal pulmonary hypertension. Pediatr Crit Care Med (2010) 1.40

Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.38

Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am (2009) 1.31

Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension. Pediatr Res (2009) 1.14

SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2010) 1.11

Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn. Respir Physiol Neurobiol (2010) 1.11

Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.09

The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol (2007) 1.08

Update on PPHN: mechanisms and treatment. Semin Perinatol (2014) 1.06

Reactive oxygen species in pulmonary vascular remodeling. Compr Physiol (2013) 1.06

Hydrogen peroxide regulates extracellular superoxide dismutase activity and expression in neonatal pulmonary hypertension. Antioxid Redox Signal (2011) 1.05

Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn. Antioxid Redox Signal (2013) 1.04

Reactive oxygen species and antioxidants in pulmonary hypertension. Antioxid Redox Signal (2012) 1.04

Decreases in manganese superoxide dismutase expression and activity contribute to oxidative stress in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol (2012) 0.99

Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells. Antioxid Redox Signal (2012) 0.96

Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 0.95

Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. Clin Perinatol (2012) 0.94

Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension. Mol Med (2012) 0.92

Role of reactive oxygen species in neonatal pulmonary vascular disease. Antioxid Redox Signal (2014) 0.91

Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways. Am J Physiol Lung Cell Mol Physiol (2013) 0.91

Pulmonary hemodynamics and vascular reactivity in asphyxiated term lambs resuscitated with 21 and 100% oxygen. J Appl Physiol (1985) (2011) 0.90

Diagnosis and treatment of pulmonary hypertension in infancy. Early Hum Dev (2013) 0.88

Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol (2011) 0.87

Impaired voltage gated potassium channel responses in a fetal lamb model of persistent pulmonary hypertension of the newborn. Pediatr Res (2009) 0.86

Risk factors for persistent pulmonary hypertension of the newborn. Pulm Circ (2012) 0.86

The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease. Antioxid Redox Signal (2014) 0.84

Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol (2011) 0.84

The myocardial architecture changes in persistent pulmonary hypertension of the newborn in an ovine animal model. Pediatr Res (2015) 0.83

Nitric oxide and beyond: new insights and therapies for pulmonary hypertension. J Perinatol (2008) 0.82

The pulmonary circulation in neonatal respiratory failure. Clin Perinatol (2012) 0.82

Cyclic stretch induces inducible nitric oxide synthase and soluble guanylate cyclase in pulmonary artery smooth muscle cells. Int J Mol Sci (2013) 0.81

Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep. Pediatr Res (2009) 0.81

Tracheal suctioning improves gas exchange but not hemodynamics in asphyxiated lambs with meconium aspiration. Pediatr Res (2014) 0.80

Pulmonary arterial responses to reactive oxygen species are altered in newborn piglets with chronic hypoxia-induced pulmonary hypertension. Pediatr Res (2011) 0.80

The protective role of MnTBAP in oxidant-mediated injury and inflammation in a rat model of lung contusion. Surgery (2013) 0.80

PGC-1α induction in pulmonary arterial hypertension. Oxid Med Cell Longev (2012) 0.79

Therapeutic approaches using nitric oxide in infants and children. Free Radic Biol Med (2011) 0.79

Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide. Semin Perinatol (2016) 0.79

Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates. J Perinatol (2016) 0.79

Inhaled NO in the experimental setting. Early Hum Dev (2008) 0.78

Blunted hypoxic pulmonary vasoconstriction in experimental neonatal chronic lung disease. Am J Respir Crit Care Med (2008) 0.78

Oxidative stress is associated with increased pulmonary artery systolic pressure in humans. Hypertension (2014) 0.77

Antenatal betamethasone improves postnatal transition in late preterm lambs with persistent pulmonary hypertension of the newborn. Pediatr Res (2013) 0.76

Challenges, priorities and novel therapies for hypoxemic respiratory failure and pulmonary hypertension in the neonate. J Perinatol (2016) 0.75

Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models. Physiol Rep (2016) 0.75

The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy. J Perinatol (2016) 0.75

Factors relating caesarean section to persistent pulmonary hypertension of the newborn. World J Pediatr (2017) 0.75

Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation. Arterioscler Thromb Vasc Biol (2017) 0.75

Articles cited by this

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol (1996) 13.14

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med (1997) 3.13

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med (1997) 3.13

Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics (2000) 2.71

Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol (2004) 2.66

Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics (2003) 2.20

Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am J Respir Cell Mol Biol (2005) 2.04

Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res (2003) 2.01

Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem (2000) 1.97

Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J Pediatr (1993) 1.71

Nitric oxide and oxygen radicals: a question of balance. FEBS Lett (1995) 1.70

Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation. Pediatr Res (2005) 1.66

Effects of recombinant human superoxide dismutase during reoxygenation with 21% or 100% oxygen after cerebral asphyxia in newborn piglets. J Matern Fetal Neonatal Med (2003) 1.40

Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am J Respir Crit Care Med (2001) 1.30

Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol (2001) 1.28

Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res (1989) 1.27

Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol (1993) 1.16

Developmental differences in endothelium-dependent responses in isolated ovine pulmonary arteries and veins. Am J Physiol (1993) 1.15

Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid Redox Signal (2003) 1.10

Chronic O2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane. J Appl Physiol (1985) (2003) 1.02

Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb. Am J Physiol Lung Cell Mol Physiol (2005) 1.00

Nitric oxide-related oxidants in acute lung injury. New Horiz (1995) 0.98

Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle. Can J Physiol Pharmacol (1990) 0.97

Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat. Free Radic Biol Med (2004) 0.94

The pulmonary biology of isoprostanes. Antioxid Redox Signal (2005) 0.93

Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol (1985) (1993) 0.91

Postnatal changes in response to norepinephrine in the normal and pulmonary hypertensive lung. Am J Respir Crit Care Med (2004) 0.90

Eight-epi-PGF2alpha: a possible marker of lipid peroxidation in term infants with severe pulmonary disease. J Pediatr (1998) 0.89

Superoxide dismutase and catalase do not affect the pulmonary hypertensive response to group B streptococcus in the lamb. Pediatr Res (2001) 0.88

Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med (2005) 0.87

Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia. Am J Physiol (1997) 0.87

Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics (1997) 0.85

Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics (1996) 0.85

Pharmacologic interactions of exogenous lung surfactant and recombinant human Cu/Zn superoxide dismutase. Pediatr Res (1994) 0.83

Ovine bronchial-derived relaxing factor: changes with development and hyperoxic ventilation. J Appl Physiol (1985) (2006) 0.83

Localization and activity of recombinant human CuZn superoxide dismutase after intratracheal administration. Am J Physiol (1996) 0.83

Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase. J Perinatol (2000) 0.82

Update in pediatrics 2005. Am J Respir Crit Care Med (2006) 0.82

Age-related differences in vasoconstrictor responses to isoprostanes in piglet pulmonary and mesenteric vascular smooth muscle. Pediatr Res (2005) 0.81

[Anti-inflammation and anti-oxidation effects of recombinant human superoxide dismutase on acute lung injury induced by meconium aspiration in infant rats]. Zhejiang Da Xue Xue Bao Yi Xue Ban (2005) 0.81

Nitrotyrosine and NO synthases in infants with respiratory failure: influence of inhaled NO. Pediatr Pulmonol (2003) 0.80

Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue. Am J Physiol (1996) 0.79

Pulmonary vascular smooth muscle contractility. Effect of free radicals. Chest (1988) 0.78

Inhaled NO and markers of oxidant injury in infants with respiratory failure. J Perinatol (2005) 0.78

F2-isoprostane generation in isolated ferret lungs after oxidant injury or ventilated ischemia. Free Radic Biol Med (1998) 0.78

Articles by these authors

Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med (2011) 6.79

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16

Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med (2005) 3.97

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood (2004) 3.70

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet (2010) 3.15

A multibiomarker-based outcome risk stratification model for adult septic shock*. Crit Care Med (2014) 2.94

Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med (2005) 2.81

The circumplex model of affect: an integrative approach to affective neuroscience, cognitive development, and psychopathology. Dev Psychopathol (2005) 2.64

Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med (2008) 2.64

Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis. Thromb Haemost (2003) 2.59

Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology (2002) 2.59

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood (2008) 2.35

Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA (2013) 2.34

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care (2004) 2.25

Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med (2014) 2.19

Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res (2003) 2.01

Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med (2005) 1.99

Neural systems subserving valence and arousal during the experience of induced emotions. Emotion (2010) 1.97

Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med (2014) 1.97

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS. Biol Blood Marrow Transplant (2008) 1.96

Alveolar capillary dysplasia. Am J Respir Crit Care Med (2011) 1.92

Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol (2004) 1.74

Severity of illness and risk of death associated with pulmonary artery catheter use. Crit Care Med (2004) 1.72

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biol Blood Marrow Transplant (2008) 1.67

Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation. Pediatr Res (2005) 1.66

Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics. J Dev Behav Pediatr (2010) 1.63

Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Crit Care Med (2007) 1.63

Treatment of ostial lesions using the Szabo technique: a case series. Catheter Cardiovasc Interv (2008) 1.60

The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome. Pediatr Res (2005) 1.60

Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome. Ann Neurol (2003) 1.57

Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*. Crit Care Med (2014) 1.56

Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow. Circulation (2003) 1.55

Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res (2007) 1.54

Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med (2011) 1.54

A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock. Am J Respir Crit Care Med (2014) 1.53

Agreement in electrocardiogram interpretation in patients with septic shock. Crit Care Med (2011) 1.52

Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia. Crit Care Med (2003) 1.51

High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen. Biol Blood Marrow Transplant (2008) 1.46

Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine. Crit Care (2013) 1.46

Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia. Crit Care Med (2007) 1.45

A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome. Crit Care Med (2008) 1.44

Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock. Crit Care Med (2014) 1.44

Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44

The neurophysiological bases of emotion: An fMRI study of the affective circumplex using emotion-denoting words. Hum Brain Mapp (2009) 1.44

Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest (2003) 1.43

Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc Res (2007) 1.43

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect Immun (2008) 1.40

Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.38

A closer look at preschoolers' freely produced labels for facial expressions. Dev Psychol (2003) 1.37

Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol (2005) 1.37

Pulmonary hemodynamics in neonatal lambs resuscitated with 21%, 50%, and 100% oxygen. Pediatr Res (2007) 1.36

Language and the perception of emotion. Emotion (2006) 1.35

The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med (2009) 1.34

Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res (2009) 1.33

DUF1220-domain copy number implicated in human brain-size pathology and evolution. Am J Hum Genet (2012) 1.28

Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng (2005) 1.28

Maternal obesity and markers of inflammation in pregnancy. Cytokine (2009) 1.25

Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care (2012) 1.24

IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and mortality of severe sepsis. Crit Care (2011) 1.23

The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg (2005) 1.20

The relation between valence and arousal in subjective experience. Psychol Bull (2012) 1.17

Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr (2002) 1.15

Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock (2012) 1.15

Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol (2003) 1.15

Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension. Pediatr Res (2009) 1.14

Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. J Pain (2013) 1.13

SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2010) 1.11

Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn. Respir Physiol Neurobiol (2010) 1.11

The diseases treated with ECMO: focus on PPHN. Semin Perinatol (2005) 1.11

eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally. Am J Physiol Lung Cell Mol Physiol (2005) 1.11

Safety and efficacy of affinity-purified, anti-tumor necrosis factor-alpha, ovine fab for injection (CytoFab) in severe sepsis. Crit Care Med (2006) 1.11

Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. Am J Respir Crit Care Med (2014) 1.11

A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics (2011) 1.09

Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol (2003) 1.08

The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol (2007) 1.08